DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹8,397 Cr | ₹8,211 Cr | ₹7,156 Cr | ₹5,062 Cr | ₹3,753 Cr |
What is the latest Net Current Assets ratio of DIVIS LABORATORIES ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹8,397 Cr |
Mar2023 | ₹8,211 Cr |
Mar2022 | ₹7,156 Cr |
Mar2021 | ₹5,062 Cr |
Mar2020 | ₹3,753 Cr |
How is Net Current Assets of DIVIS LABORATORIES Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹8,397 Cr | 2.27 | |
Mar2023 | ₹8,211 Cr | 14.74 | |
Mar2022 | ₹7,156 Cr | 41.36 | |
Mar2021 | ₹5,062 Cr | 34.89 | |
Mar2020 | ₹3,753 Cr | - |
Compare Net Current Assets of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹160,054.0 Cr | 2.1% | 3.7% | 66.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,910.0 Cr | 2.5% | 0.2% | 17.2% | Stock Analytics | |
CIPLA | ₹125,540.0 Cr | 0.9% | 0.1% | 14.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,894.0 Cr | -0.6% | 0.4% | 28.3% | Stock Analytics | |
MANKIND PHARMA | ₹105,587.0 Cr | -1.2% | 5.6% | 11.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,110.0 Cr | -0.3% | -2.2% | -0.1% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 2.1% |
3.7% |
66.4% |
SENSEX | 1% |
4.3% |
8.9% |
You may also like the below Video Courses